|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.475 -0.005 (-1.042%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -14.000% | -12.144% | -4.865% | -8.180% | -4.449% |
| ROAE (%) | -19.114% | -16.114% | -6.813% | -12.085% | -6.436% |
| Return on Capital Employed (%) | -19.961% | -16.174% | -6.030% | -10.036% | -4.956% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 84.675% | 79.113% | 61.784% | 64.234% | 75.387% |
| EBITDA Margin (%) | -144.973% | -104.142% | -35.255% | -50.042% | -3.064% |
| Pre-tax Profit Margin (%) | -203.702% | -143.151% | -63.626% | -74.423% | -20.154% |
| Net Profit Margin (%) | -177.359% | -127.540% | -34.234% | -53.556% | -17.818% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 3.127 X | 3.549 X | 3.925 X | 4.292 X | 6.017 X |
| Quick Ratio (X) | 3.098 X | 3.533 X | 3.907 X | 4.247 X | 5.949 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 39.276% | 32.569% | 28.972% | 27.439% | 24.535% |
| Total Debt / Total Assets (%) | 17.209% | 15.686% | 15.153% | 15.329% | 15.849% |
| Net Debt / Total Assets (%) | 4.882% | 6.308% | 8.261% | 7.385% | -1.605% |
| Total Debt / Shareholders' Funds (%) | 24.015% | 21.024% | 19.936% | 22.794% | 23.281% |
| Long Term Debt / Shareholders' Funds (%) | 20.958% | 18.354% | 18.061% | 20.982% | 21.762% |
| Net Debt / Shareholders' Funds (%) | 6.812% | 8.455% | 10.869% | 10.982% | -2.358% |
| Net Cash / (Debt) ($) | (10.983M) | (16.461M) | (25.027M) | (24.632M) | 6.043M |
| Net Cash / (Debt) per share ($) | (0.028) | (0.041) | (0.063) | (0.062) | 0.015 |
| Total Debt / Capital Employed (%) | 22.720% | 19.335% | 17.878% | 17.672% | 17.544% |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | N/A | N/A |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 146.360 Day | 52.045 Day | 29.257 Day | 42.013 Day | 34.398 Day |
| Receivables Turnover (Day) | 50.312 Day | 70.199 Day | 90.298 Day | 92.856 Day | 32.042 Day |
| Payables Turnover (Day) | 67.003 Day | 54.461 Day | 32.045 Day | 13.222 Day | 0.932 Day |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -34,014 |
| %Change | -0.654% |
| EPS / (LPS) | HKD -0.085 |
| NBV Per Share ($) | HKD 0.404 |